$69.62
0.370.53%
At close: -
$96.50
26.8838.61%
After Hours: May 3, 9:29 AM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
There have been no specific sales or earnings guidance reported for Cosmo Pharmaceuticals in recent months.
Browse guidance and forecast on all stocks.